Latest placebo Stories
LOS GATOS, Calif., Feb.
Provides additional details on AT-001 pivotal efficacy study, announces two technical section complete letters for safety, provides manufacturing update for AT-004, and announces completion of enrollment
CAMBIA® (Diclofenac Potassium for Oral Solution) is elevated to Level A, based on rigorous clinical data demonstrating its effectiveness for acute migraine attacks, consistent with other therapies
Reduction in the Frequency of Sickle Cell Crisis, Frequency in Hospitalizations, Hospital Days and Fewer Cases of Acute Chest Syndrome Highlighted in Abstract TORRANCE, Calif., Feb.
LEXINGTON, Mass., Jan. 30, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S.
- Nuvo to Host Conference Call/Webcast at 8:30 a.m. ET - MISSISSAUGA, ON, Jan. 30, 2015 /PRNewswire/ - Nuvo Research Inc.
MELBOURNE, Australia, Jan.
Studies Further Confirm PERCEPTIV™ Improves Cognitive Performance Waltham, MA (PRWEB) January 15, 2015
Onnit’s flagship Earth grown nutrient based supplement, Alpha BRAIN, demonstrates statistically significant cognitive improvement for healthy, intelligent adults in a double blind, placebo controlled,
LONDON, January 7, 2015 /PRNewswire/ -- ~ Shield seeks approval of Feraccru for the treatment of iron deficiency
- Large; stout; burly.